Recognition of Mycoplasma hyorhinis by CD99-Fc molecule

European Journal of Immunology

Volumn 34, Issue 7, 2004, Pages 2032-2040

  Gazit, Roi ^a   Rechnitzer, Hagai ^a   Achdout, Hagit ^a   Katzenell, Avigail ^a   Katz, Gil ^a   Markel, Gal ^a   Arnon, Tal I ^a   Gonen Gross, Tsufit ^a   Mizrahi, Sa'ar ^a   Gruda, Raizy ^a   Rottem, Shlomo ^a   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Fusion protein; Lymphocyte receptor; Mycoplasma; Mycoplasma hyorhinis; NK cells

Indexed keywords

CD99 ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN G1; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; RNA 16S; RNA 23S; CD99 PROTEIN, HUMAN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN; LIGAND;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; CANCER CELL CULTURE; CELL ACTIVATION; CELL ADHESION; CELL TYPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE; MELANOMA CELL; MOLECULAR RECOGNITION; MYCOPLASMA; MYCOPLASMA HYORHINIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SEQUENCE ANALYSIS; STAINING; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME SPECIFICITY; GENETICS; MELANOMA; METABOLISM; MICROBIOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL ADHESION MOLECULES; CELL LINE; CELL LINE, TUMOR; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; LIGANDS; MELANOMA; MYCOPLASMA HYORHINIS; MYCOPLASMA INFECTIONS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY;

EID: 4544276815     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324845     Document Type: Article

References (64)

1. Goodfellow, P., Banting, G., Sheer, D., Ropers, H. H., Caine, A., Ferguson-Smith, M. A., Povey, S. and Voss, R., Genetic evidence that a Y-linked gene in man is homologous to a gene on the X chromosome. Nature 1983. 302: 346-349.
2. Gelin, C., Aubrit, F., Phalipon, A., Raynal, B., Cole, S., Kaczorek, M. and Bernard, A., The E2 antigen, a 32 kd glycoprotein involved in T cell adhesion processes, is the MIC2 gene product. EMBO J. 1989. 8: 3253-3259.
3. Bernard, A., Leukocyte typing VI. Proceedings of the VIth International Leukocyte Differentiation Antigen Workshop, Kobe, Japan, 1996. Garland Publisher, London 1997.
4. Schenkel, A. R., Mamdouh, Z., Chen, X., Liebman, R. M. and Muller, W. A., CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 2002. 3: 143-150.
5. Dworzak, M. N., Fritsch, G., Buchinger, P., Fleischer, C., Printz, D., Zellner, A., Schollhammer, A., Steiner, G., Ambros, P. F. and Gadner, H., Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood. Blood 1994. 83: 415-425.
6. Tippett, P., What is important on the red blood cell surface. Immunol. Invest. 1995. 24: 173-186.
7. Park, C. K., Shin, Y. K., Kim, T. J., Park, S. H. and Ahn, G. H., High CD99 expression in memory T and B cells in reactive lymph nodes. J. Korean Med. Sci. 1999. 14: 600-606.
8. Kovar, H., Dworzak, M., Strehl, S., Schnell, E., Ambros, I. M., Ambros, P. F. and Gadner, H., Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene 1990. 5: 1067-1070.
9. Ambros, I. M., Ambros, P. F., Strehl, S., Kovar, H., Gadner, H. and Salzer-Kuntschik, M., MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991. 67: 1886-1893.
10. Perlman, E. J., Dickman, P. S., Askin, F. B., Grier, H. E., Miser, J. S. and Link, M. P., Ewing's sarcoma - routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup study. Hum. Pathol. 1994. 25: 304-307.
11. + thymocytes. J. Immunol. 1995. 154: 26-32.
12. Hahn, J. H., Kim, M. K., Choi, E. Y., Kim, S. H., Sohn, H. W., Ham, D. I., Chung, D. H., Kim, T. J., Lee, W. J., Park, C. K., Ree, H. J. and Park, S. H., CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J. Immunol. 1997. 159: 2250-2258.
13. Kasinrerk, W., Tokrasinwit, N., Moonsom, S. and Stockinger, H., CD99 monoclonal antibody induce homotypic adhesion of Jurkat cells through protein tyrosine kinase and protein kinase C-dependent pathway. Immunol. Lett. 2000. 71: 33-41.
14. Hahn, M. J., Yoon, S. S., Sohn, H. W., Song, H. G., Park, S. H. and Kim, T. J., Differential activation of MAP kinase family members triggered by CD99 engagement. FEBS Lett. 2000. 470: 350-354.
15. Waclavicek, M., Majdic, O., Stulnig, T., Berger, M., Sunder-Plassmann, R., Zlabinger, G. J., Baumruker, T., Stockl, J., Ebner, C., Knapp, W. and Pickl, W. F., CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J. Immunol. 1998. 161: 4671-4678.
16. Wingett, D., Forcier, K. and Nielson, C. P., A role for CD99 in T cell activation. Cell. Immunol. 1999. 193: 17-23.
17. Bernard, G., Breittmayer, J. P., de Matteis, M., Trampont, P., Hofman, P., Senik, A. and Bernard, A., Apoptosis of immature thymocytes mediated by E2/CD99. J. Immunol. 1997. 158: 2543-2550.
18. Sohn, H. W., Choi, E. Y., Kim, S. H., Lee, I. S., Chung, D. H., Sung, U. A., Hwang, D. H., Cho, S. S., Jun, B. H., Jang, J. J., Chi, J. G. and Park, S. H., Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells. Am. J. Pathol. 1998. 153: 1937-1945.
19. Pettersen, R. D., Bernard, G., Olafsen, M. K., Pourtein, M. and Lie, S. O., CD99 signals caspase-independent T cell death. J. Immunol. 2001. 166: 4931-4942.
20. Choi, E. Y., Park, W. S., Jung, K. C., Kim, S. H., Kim, Y. Y., Lee, W. J. and Park, S. H., Engagement of CD99 induces up-regulation of TCR and MHC class I and II molecules on the surface of human thymocytes. J. Immunol. 1998. 161: 749-754.
21. Sohn, H. W., Shin, Y. K., Lee, I. S., Bae, Y. M., Suh, Y. H., Kim, M. K., Kim, T. J., Jung, K. C., Park, W. S., Park, C. S., Chung, D. H., Ahn, K., Kim, I. S., Ko, Y. H., Bang, Y. J., Kim, C. W. and Park, S. H., CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface. J. Immunol. 2001. 166: 787-794.
22. Yoon, S. S., Jung, K. I., Choi, Y. L., Choi, E. Y., Lee, I. S., Park, S. H. and Kim, T. J., Engagement of CD99 triggers the exocytic transport of ganglioside GM1 and the reorganization of actin cytoskeleton. FEBS Lett. 2003. 540: 217-222.
23. Alberti, I., Bernard, G., Rouquette-Jazdanian, A. K., Pelassy, C., Pourtein, M., Aussel, C. and Bernard, A., CD99 isoforms expression dictates T cell functional outcomes. FASEB J. 2002. 16: 1946-1948.
24. Razin, S., Yogev, D. and Naot, Y., Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev. 1998. 62: 1094-1156.
25. Rottem, S., Interaction of mycoplasmas with host cells. Physiol. Rev. 2003. 83: 417-432.
26. Wise, K. S. and Watson, R. K., Antigenic mimicry of mammalian intermediate filaments by mycoplasmas. Infect. Immun. 1985. 48: 587-591.
27. Wren, B. W., Microbial genome analysis: insights into virulence, host adaptation and evolution. Nat. Rev. Genet. 2000. 1: 30-39.
28. Ruuth, E. and Praz, F., Interactions between mycoplasmas and the immune system. Immunol. Rev. 1989. 112: 133-160.
29. Naot, Y., Mycoplasmas as immunomodulators. In Kahane, I. and Adoni, A. (Eds.) Rapid diagnosis of mycoplasmas. Plenum Press, New York 1993, pp 57-67.
30. Simecka, J. W., Ross, S. E., Cassell, G. H. and Davis, J. K., Interactions of mycoplasmas with B cells: antibody production and nonspecific effects. Clin. Infect. Dis. 1993. 17: S176-S182.
31. Rottem, S. and Naot, Y., Subversion and exploitation of host cells by mycoplasmas. Trends Microbiol. 1998. 6: 436-440.
32. Friis, N. F. and Feenstra, A. A., Mycoplasma hyorhinis in the etiology of serositis among piglets. Acta Vet. Scand. 1994. 35: 93-98.
33. Morita, T., Fukuda, H., Awakura, T., Shimada, A., Umemura, T., Kazama, S. and Yagihashi, T., Demonstration of Mycoplasma hyorhinis as a possible primary pathogen for porcine otitis media. Vet. Pathol. 1995. 32: 107-111.
34. Huang, S., Li, J. Y., Wu, J., Meng, L. and Shou, C. C., Mycoplasma infections and different human carcinomas. World J. Gastroenterol. 2001. 7: 266-269.
35. Woods, S. B., The isolation of a 'non-cultivable' strain of Mycoplasma hyorhinis from a mammalian live virus vaccine. J. Biol. Stand. 1983. 11: 247-250.
36. Kotani, H., Butler, G. H., Tallarida, D., Cody, C. and McGarrity, G. J., Microbiological cultivation of Mycoplasma hyorhinis from cell cultures. In Vitro Cell Dev. Biol. 1990. 26: 91-96.
37. Gelin, C., Zoccola, D., Valentin, H., Raynal, B. and Bernard, A., Isoforms of the E2 molecule: D44 monoclonal antibody defines an epitope on E2 and reacts differentially with T cell subsets. Eur. J. Immunol. 1991. 21: 715-719.
38. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, J., Angman, L., Cella, M. and Lopez-Botet, M., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
39. Mandelboim, O., Reyburn, H. T., Vales-Gomez, M., Pazmany, L., Colonna, M., Borsellino, G. and Strominger, J. L., Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 1996. 184: 913-922.
40. Kong, F., James, G., Gordon, S., Zelynski, A. and Gilbert, G. L., Species-specific PCR for identification of common contaminant mollicutes in cell culture. Appl. Environ. Microbiol. 2001. 67: 3195-3200.
41. Rosengarten, R. and Wise, K. S., Phenotypic switching in mycoplasmas: phase variation of diverse surface lipoproteins. Science 1990. 247: 315-318.
42. Citti, C., Kim, M. F. and Wise, K. S., Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies. Infect. Immun. 1997. 65: 1773-1785.
43. Rottem, S. and Barile, M. F., Beware of mycoplasmas. Trends Biotechnol. 1993. 11: 143-151.
44. Aubrit, F., Gelin, C., Pham, D., Raynal, B. and Bernard, A., The biochemical characterization of E2, a T cell surface molecule involved in rosettes. Eur. J. Immunol. 1989. 19: 1431-1436.
45. Butler, G. H. and Stanbridge, E. J., Infection of mouse lymphoblastoid cell lines with Mycoplasma hyorhinis: complex nature of mycoplasma-host cell interactions. Infect. Immun. 1983. 42: 1136-1143.
46. Scotlandi, K., Baldini, N., Cerisano, V., Manara, M. C., Benini, S., Serra, M., Lollini, P. L., Nanni, P., Nicoletti, G., Bernard, G., Bernard, A. and Picci, P., CD99 engagement: an effective therapeutic strategy for Ewing tumors. Cancer Res. 2000. 60: 5134-5142.
47. Dudler, R., Schmidhauser, C., Parish, R. W., Wettenhall, R. E. and Schmidt, T., A mycoplasma high-affinity transport system and the in vitro invasiveness of mouse sarcoma cells. EMBO J. 1988. 7: 3963-3970.
48. Schmidhauser, C., Dudler, R., Schmidt, T. and Parish, R. W., A mycoplasmal protein influences tumour cell invasiveness and contact inhibition in vitro. J. Cell Sci. 1990. 95: 499-506.
49. Lee, H. J., Kim, E., Jee, B., Hahn, J. H., Han, K., Jung, K. C., Park, S. H. and Lee, H., Functional involvement of src and focal adhesion kinase in a CD99 splice variant-induced motility of human breast cancer cells. Exp. Mol. Med. 2002. 34: 177-183.
50. Jung, K. C., Park, W. S., Bae, Y. M., Hahn, J. H., Hahn, K., Lee, H., Lee, H. W., Koo, H. J., Shin, H. J., Shin, H. S., Park, Y. E. and Park, S. H., Immunoreactivity of CD99 in stomach cancer. J. Korean Med. Sci. 2002. 17: 483-489.
51. Paddenberg, R., Weber, A., Wulf, S. and Mannherz, H. G., Mycoplasma nucleases able to induce internucleosomal DNA degradation in cultured cells possess many characteristics of eukaryotic apoptotic nucleases. Cell Death Differ. 1998. 5: 517-528.
52. Butler, G. H., Gobel, U. and Stanbridge, E. J., Blast transformation of mouse splenic B-lymphocytes with extracts of Mycoplasma hyorhinis. Isr. J. Med. Sci. 1984. 20: 891-894.
53. Teh, H. S., Ho, M. and Williams, L. D., Suppression of cytotoxic responses by a supernatant factor derived from Mycoplasma hyorhinis-infected mammalian cell lines. Infect. Immun. 1988. 56: 197-203.
54. Kita, M., Ohmoto, Y., Hirai, Y., Yamaguchi, N. and Imanishi, J., Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol. Immunol. 1992. 36: 507-516.
55. Proust, J. J., Buchholz, M. A. and Nordin, A. A., A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination. J. Immunol. 1985. 134: 390-396.
56. Bernard, G., Raimondi, V., Alberti, I., Pourtein, M., Widjenes, J., Ticchioni, M. and Bernard, A., CD99 (E2) up-regulates alpha4beta1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions. Eur. J. Immunol. 2000. 30: 3061-3065.
57. Kim, S. H., Choi, E. Y., Shin, Y. K., Kim, T. J., Chung, D. H., Chang, S. I., Kim, N. K. and Park, S. H., Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (MIC2). Blood 1998. 92: 4287-4295.
58. Porgador, A., Mandelboim, O., Restifo, N. P. and Strominger, J. L., Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. Proc. Natl. Acad. Sci. USA 1997. 94: 13140-13145.
59. Shimizu, Y. and DeMars, R., Prpduction of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 1989. 142: 3320-3328.
60. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W. and Porgador, A., Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001. 409: 1055-1060.
61. Deutsch, J., Salman, M. and Rottem, S., An unusual polar lipid from the cell membrane of Mycoplasma fermentans. Eur. J. Biochem. 1995. 227: 897-902.
62. Mandelboim, O., Malik, P., Davis, D. M., Jo, C. H., Boyson, J. E. and Strominger, J. L., Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc. Natl. Acad. Sci. USA 1999. 96: 5640-5644.
63. Katz, G., Markel, G., Mizrahi, S., Annon, T. I. and Mandelboim, O., Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J. Immunol. 2001. 166: 7260-7267.
64. Gonen-Gross, T., Achdout, H., Gazit, R., Hanna, J., Mizrahi, S., Markel, G., Goldman-Wohl, D., Yagel, S., Horejsi, V. V., Levy, O., Baniyash, M. and Mandelboim, O., Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J. Immunol. 2003. 171: 1343-1351.